Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
228.00    -1.50 (-0.65%)
Bid:
227.00
Ask:
227.50
Spread: 0.50 (0.22%)
Market Cap: £630.23m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Trading Update

12 Nov 2015 07:00

RNS Number : 4277F
Morgan Advanced Materials PLC
12 November 2015
 



 

Press Release

Trading Update

Morgan Advanced Materials plc

12th November 2015

 

 

Morgan Advanced Materials plc, the advanced materials company, is today issuing the following trading update covering the period from 1st July 2015 to 11th November 2015.

 

Trading conditions in the period since the half year have weakened across the Group with North America and China particularly affected by deteriorating demand. Overall our order book has mirrored this weakness, but with a mixed profile across the geographies, businesses and end markets in which we operate.

 

At the end of October the YTD book to bill ratio was 1.00 (June 2015 -1.03). The outstanding order book at the end of October was 5.3% below last year (June 2015 - 5.7% higher than the June 2014). Given this order profile, the Group expects that reported revenue in the second half of the year will be c7% below the first half of 2015 and that EBITA before restructuring and one-offs will be around the lower end of the range of analyst expectations.

 

The North American region has been the most affected by economic slowdown. General industrial demand weakness has been seen across our business over the last four months particularly oil and gas, transportation and mining markets.

 

In Europe the Thermal Ceramics business has continued to trade well, offset by weak demand in Technical Ceramics, Seals and Bearings and Composites and Defence Systems.

 

Asia/ROW has continued to see very weak demand in China, which has impacted both the products manufactured in-region for industrial markets and also those sold in to China from Morgan businesses in North America and Europe. The rest of Asia has shown some weakness in parts of its demand environment, but overall has been fairly resilient. Weak economic conditions in South America, particularly in Brazil and Argentina, are impacting the performance of our mainly industrial business in the region.

 

The Group is cautious about the trading and macro-economic environment for the rest of this year, and into 2016, and the Group has undertaken a range of cost reduction measures in line with this weakening economic environment and will continue to take further action as necessary. The cash cost for these restructuring and one-off items is estimated to be low, in the region of £3 million. Against this challenging market, the Group continues to invest in R&D and profitable growth opportunities which are critical for the future. Such investment is underpinned by solid cash flow and a strong balance sheet, with low net debt estimated to be c1.5 times EBITDA at the end of 2015.

 

Morgan's preliminary results for the year ended 31st December 2015 will be announced on 23rd February 2016.

 

(Note:

Current market expectations compiled from analyst notes for EBITA before restructuring and one-off items range from £110.0 million to £121.5 million).

 

 

 

 

 

 

For further enquiries:

 

Pete Raby/Kevin Dangerfield

Morgan Advanced Materials plc

01753 837000

Mike Smith/Nina Coad

Brunswick

0207 404 5959

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKDDDFBDDODD
Date   Source Headline
1st Jun 20264:35 pmRNSDirector/PDMR Shareholding
28th May 202610:10 amRNSHolding(s) in Company
26th May 20265:21 pmRNSDirector/PDMR Shareholding
18th May 20262:53 pmRNSHolding(s) in Company
13th May 20265:26 pmRNSHolding(s) in Company
12th May 20262:09 pmRNSDirector/PDMR Shareholding
7th May 20261:19 pmRNSResult of AGM
7th May 20267:00 amRNSCFO Intention to retire
7th May 20267:00 amRNSAGM Trading Update
29th Apr 20264:23 pmRNSDirector/PDMR Shareholding
9th Apr 20263:51 pmRNSHolding(s) in Company
31st Mar 20261:16 pmRNSDirector/PDMR Shareholding
26th Mar 20265:39 pmRNSDirector/PDMR Shareholding
26th Mar 20269:53 amRNSAnnual Financial Report
24th Mar 20262:44 pmRNSDirector/PDMR Shareholding
9th Mar 20269:34 amRNSDirector/PDMR Shareholding
5th Mar 20269:30 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSFull Year Results
23rd Feb 20269:00 amRNSHolding(s) in Company
2nd Feb 20264:12 pmRNSTotal Voting Rights
2nd Feb 20269:30 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202611:57 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 202512:00 pmRNSBlock listing Interim Review
22nd Dec 202512:00 pmRNSBlock listing Interim Review
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.